287 related articles for article (PubMed ID: 33980221)
21. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway.
Wu Y; Lin Y; Pan J; Tu X; Xu Y; Li H; Chen Y
Cancer Cell Int; 2021 Aug; 21(1):443. PubMed ID: 34419073
[TBL] [Abstract][Full Text] [Related]
22. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
23. High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
Deng H; Hang Q; Shen D; Ying H; Zhang Y; Qian X; Chen M
Front Mol Biosci; 2021; 8():653805. PubMed ID: 34307447
[No Abstract] [Full Text] [Related]
24. A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside.
Wang X; Xiao Z; Gong J; Liu Z; Zhang M; Zhang Z
Transl Lung Cancer Res; 2021 Jan; 10(1):167-182. PubMed ID: 33569302
[TBL] [Abstract][Full Text] [Related]
25. Identifying liver metastasis-related hub genes in breast cancer and characterizing
Chen M; Zheng W; Fang L
PeerJ; 2023; 11():e15311. PubMed ID: 37180578
[TBL] [Abstract][Full Text] [Related]
26. Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma
Li Z; Fei H; Lei S; Hao F; Yang L; Li W; Zhang L; Fei R
PeerJ; 2021; 9():e12624. PubMed ID: 35036134
[TBL] [Abstract][Full Text] [Related]
27. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.
Feng Z; Zhang J; Zheng Y; Liu J; Duan T; Tian T
Transl Cancer Res; 2021 Feb; 10(2):983-997. PubMed ID: 35116426
[TBL] [Abstract][Full Text] [Related]
29. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
[TBL] [Abstract][Full Text] [Related]
30. Validating
Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
Front Oncol; 2021; 11():720302. PubMed ID: 34527588
[TBL] [Abstract][Full Text] [Related]
31. Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database.
Shen Y; Tang X; Zhou X; Yi Y; Qiu Y; Xu J; Tian X
J Oncol; 2022; 2022():4435092. PubMed ID: 36600965
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Wang F; Zhao N; Gao G; Deng HB; Wang ZH; Deng LL; Yang Y; Lu C
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2851-2859. PubMed ID: 32743759
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma.
Qin RX; Yang Y; Chen JF; Huang LJ; Xu W; Qin QC; Liang XJ; Lai XY; Huang XY; Xie MS; Chen L
Front Neurol; 2023; 14():1119160. PubMed ID: 37265472
[TBL] [Abstract][Full Text] [Related]
34. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
35. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis.
Chen Y; Jin L; Jiang Z; Liu S; Feng W
Front Oncol; 2021; 11():644426. PubMed ID: 33937050
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
38. NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.
Zhao C; Liu J; Zhou H; Qian X; Sun H; Chen X; Zheng M; Bian T; Liu L; Liu Y; Zhang J
Cancer Cell Int; 2021 Apr; 21(1):228. PubMed ID: 33879165
[TBL] [Abstract][Full Text] [Related]
39. Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.
Liu L; Xu S; Huang L; He J; Liu G; Ma S; Weng Y; Huang S
Transl Cancer Res; 2021 Jun; 10(6):2859-2872. PubMed ID: 35116596
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma.
Guo T; Ma H; Zhou Y
PeerJ; 2019; 7():e7313. PubMed ID: 31333911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
